Effect of polymorphisms in the 3′ untranslated region (3′-UTR) of vascular endothelial growth factor gene on gastric cancer and peptic ulcer diseases in Japan

Molecular Carcinogenesis

Volumn 48, Issue 11, 2009, Pages 1030-1037

  Tahara, Tomomitsu ^a   Shibata, Tomoyuki ^a   Nakamura, Masakatsu ^a   Yamashita, Hiromi ^a   Yoshioka, Daisuke ^a   Hirata, Ichiro ^a   Arisawa, Tomiyasu ^b  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

Gastric cancer; H. pylori; Polymorphism; VEGF

Indexed keywords

VASCULOTROPIN;

3' UNTRANSLATED REGION; ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER RISK; CONTROLLED STUDY; DUODENUM ULCER; FEMALE; GENETIC SUSCEPTIBILITY; GENOTYPE PHENOTYPE CORRELATION; HETEROZYGOTE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH CANCER; STOMACH ULCER;

3' UNTRANSLATED REGIONS; GENOTYPE; HUMANS; JAPAN; PEPTIC ULCER; POLYMORPHISM, GENETIC; STOMACH NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

HELICOBACTER PYLORI;

EID: 70350447017     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20554     Document Type: Article

References (42)

1. NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. JAMA 1994;272:65-69. (Pubitemid 24195449)
2. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001;345:784-789. (Pubitemid 34940841)
3. Parsonnet J, Friedman GD, Vandersteen DP, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991;325:1127-1131.
4. Huang JQ, Sridhar S, Chen Y, Hunt RH.Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology 1998;114:1169-1179. (Pubitemid 28243902)
5. Blaser MJ, Parsonnet J. Parasitism by the "slow" bacterium Helicobacter pylori leads to altered gastric homeostasis and neoplasia. J Clin Invest 1998;94:4-8.
6. Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J. Vascular-specific growth factors and blood vessel formation. Nature 2000;407:242-248.
7. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000;407:249-257.
8. Dvorak HF, Brown LF, Detmar M, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 1995;146:1029-1039.
9. Jones MK, Wang H, Peskar BM, et al. Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: Insight into mechanisms and implications for cancer growth and ulcer healing. Nat Med 1999;5:1418-1423.
10. Jones MK, Kawanaka H, Baatar D, et al. Gene therapy for gastric ulcers with single local injection of naked DNA encoding VEGF and angiopoietin-1. Gastroenterology 2001;121:1040-1047. (Pubitemid 33022082)
11. Suzuki N, Takahashi S, Okabe S. Relationship between vascular endothelial growth factor and angiogenesis in spontaneous and indomethacin-delayed healing of acetic acid-induced gastric ulcers in rats. J Physiol Pharmacol 1998;49:515-527. (Pubitemid 29024370)
12. Takahashi Y, Cleary KR, Mai M, Kitadai Y, Bucana CD, Ellis LM. Significance of vessel count and vascular endothelial growth factor and its receptor (KDR) in intestinal-type gastric cancer. Clin Cancer Res 1996;2:1679-1684. (Pubitemid 26356351)
13. Maeda K, Kang SM, Onoda N, et al. Vascular endothelial growth factor expression in preoperative biopsy specimens correlates with disease recurrence in patients with early gastric carcinoma. Cancer 1999;86:566-571. (Pubitemid 29379401)
14. Feng CW, Wang LD, Jiao LH, Liu B, Zheng S, Xie XJ. Expression of p53, inducible nitric oxide synthase and vascular endothelial growth factor in gastric precancerous and cancerous lesions: Correlation with clinical features. BMC Cancer 2000;29:2-8. (Pubitemid 38851313)
15. Renner W, Kotschan S, Hoffmann C, Obermayer-Pietsch B, Pilger E. A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. J Vasc Res 2000;37:443-448. (Pubitemid 32037619)
16. Abe A, Sato K, Habuchi T, et al. Single nucleotide polymorphisms in the 3′ untranslated region of vascular endothelial growth factor gene in Japanese population with or without renal cell carcinoma. Tohoku J Exp Med 2002;198:181-190. (Pubitemid 36305121)
17. Awata T, Inoue K, Kurihara S, et al. A common polymorphism in the 50-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes 2002;51:1635-1639. (Pubitemid 34826636)
18. Lauren P. The two histological main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965;64:31-49.
19. Morohashi K, Takada T,Omori K, Suzuki E, Gejyo F. Vascular endothelial growth factor gene polymorphisms in Japanese patients with sarcoidosis. Chest 2003;123:1520-1526. (Pubitemid 36549771)
20. Caputo R, Tuccillo C, Manzo BA, et al. Helicobacter pylori VacA toxin up-regulates vascular endothelial growth factor expression in MKN 28 gastric cells through an epidermal growth factor receptor-, cyclooxygenase-2-dependent mechanism. Clin Cancer Res 2003;9:2015-2021. (Pubitemid 36687620)
21. Kitadai Y, Sasaki A, ItoM, et al. Helicobacter pylori infection influences expression of genes related to angiogenesis and invasion in human gastric carcinoma cells. Biochem Biophys Res Common 2003;311:809-814. (Pubitemid 37393390)
22. Dibbens JA, Miller DL, Damert A, Risau W, Vadas MA, Goodall CJ. Hypoxic regulation of vascular endothelial growth factor mRNA stability requires the cooperation of multiple RNA elements. Mol Biol Cell 1999;10:907-919. (Pubitemid 29193720)
23. Greener MJ, Sewry CA, Muntoni F, Roberts RG. The 30-untranslated region of the dystrophin gene - Conservation and consequences of loss. Eur J Hum Genet 2002;10:413-420. (Pubitemid 34893594)
24. Iida K, Kawakami Y, Sone H, et al. Vascular endothelial growth factor gene expression in a retinal pigmented cell is up-regulated by glucose deprivation through 3′ UTR. Life Sci 2002;71:1607-1614. (Pubitemid 34874487)
25. Ma WJ, Cheng S, Campbell C, Wright A, Furneaux H. Cloning and characterization of HuR, a ubiquitously expressed Elav-like protein. J Biol Chem 1996;271:8144-8151. (Pubitemid 26108641)
26. Nabors LB, Gillespie GY, Harkins L, King PH. HuR, a RNA stability factor, is expressed in malignant brain tumors and binds to adenine- and uridine-rich elements within the 3′ untranslated regions of cytokine and angiogenic factor mRNAs. Cancer Res 2001;61:2154-2161. (Pubitemid 32692041)
27. Goldberg-Cohen I, Furneauxb H, Levy AP. A 40-bp RNA element that mediates stabilization of vascular endothelial growth factor mRNA by HuR. J Biol Chem 2002;277:13635-13640. (Pubitemid 34967963)
28. Ramamoorti N, Kumarvelu J, Shanmugasundaram GK, Rani K, Banerjea AC. High frequency of G to A transition mutation in the stromal cell derived factor-1 gene in India, a chemokine that blocks HIV-1 (X4) infection: Multiple proteins bind to 30-untranslated region of SDF-1 RNA. Genes Immun 2001;2:408-410.
29. Tzanakis N, Gazouli M, Rallis G, et al. Vascular endothelial growth factor polymorphisms in gastric cancer development, prognosis, and survival. J Surg Oncol 2006;94:624-630. (Pubitemid 44851925)
30. Chae YS, Kim JG, Sohn SK, et al. Investigation of vascular endothelial growth factor gene polymorphisms and its association with clinicopathologic characteristics in gastric cancer. Oncology 2006;71:266-272.
31. Kim JG, Sohn SK, Chae YS, et al. Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with gastric cancer. Ann Oncol 2007;18:1030-1036. (Pubitemid 47050494)
32. Ke Q, Liang J, Wang LN, et al. Potentially functional polymorphisms of the vascular endothelial growth factor gene and risk of gastric cancer. Mol Carcinog 2008;47:647-651.
33. Langsenlehner T, Langsenlehner U, Renner W, et al. Single nucleotide polymorphisms and haplotypes in the gene for vascular endothelial growth factor and risk of prostate cancer. Eur J Cancer 2008;44:1572-1576.
34. Correa P.Helicobacter pylori and gastric carcinogenesis. Am J Surg Pathol 1995;19:S37-S43.
35. El-Omar EM, Penman ID, Ardill JE, Chittajallu RS, Howie C, McColl KE. Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease. Gastroenterology 1995;109:681-691.
36. Lee S, Iida M, Yao T, et al. Risk of gastric cancer in patients with non-surgically treated peptic ulcer. Scand J Gastroenterol 1990;25:1223-1226.
37. Jemal A, Tiwai RC, Murray T, et al. Cancer statistics 2004. CA Cancer J Clin 2004;54:8-29.
38. Ekstrom AM, Held M, Hansson LE, Engstrand L, Nyren O. Helicobacter pylori in gastric cancer established by CagA immunoblot as amarker of past infection. Gastroenterology 2001;121:784-791. (Pubitemid 32959388)
39. Forman D, Weeb P, Parsonnet J. H. pylori and gastric cancer. Lancet 1994;343:243-244.
40. Uemura N,Mukai T, Okamoto S, et al. Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. Cancer Epidemiol Biomarkers Prev 1997;6:639-642. (Pubitemid 27342688)
41. Wong BC, Lam SK, Wong WM, et al. China Gastric Cancer Study Group. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: A randomized controlled trial. JAMA 2004;291:187-194.
42. Hosokawa O, Tsuda S, Kidani E, et al. Diagnosis of gastric cancer up to three years after negative upper gastrointestinal endoscopy. Endoscopy 1998;30:721-723. (Pubitemid 28528739)